Twist Bioscience Corp Stock Fundamentals
| TWST Stock | USD 30.75 0.75 2.38% |
Twist Bioscience Corp fundamentals help investors to digest information that contributes to Twist Bioscience's financial success or failures. It also enables traders to predict the movement of Twist Stock. The fundamental analysis module provides a way to measure Twist Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Twist Bioscience stock.
At this time, Twist Bioscience's Cost Of Revenue is comparatively stable compared to the past year. Income Tax Expense is likely to gain to about 1.1 M in 2024, whereas Operating Income is likely to drop (205.2 M) in 2024. Twist | Select Account or Indicator |
Twist Bioscience Corp Company Return On Equity Analysis
Twist Bioscience's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Twist Bioscience Return On Equity | -0.31 |
Most of Twist Bioscience's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Twist Bioscience Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Twist Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Twist Bioscience Corp has a Return On Equity of -0.308. This is 98.72% lower than that of the Biotechnology sector and 95.39% lower than that of the Health Care industry. This indicator is about the same for all United States stocks average (which is currently at -0.31).
Twist Bioscience Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Twist Bioscience's current stock value. Our valuation model uses many indicators to compare Twist Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Twist Bioscience competition to find correlations between indicators driving Twist Bioscience's intrinsic value. More Info.Twist Bioscience Corp is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . At this time, Twist Bioscience's Return On Equity is comparatively stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Twist Bioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Twist Bioscience's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Twist Bioscience's earnings, one of the primary drivers of an investment's value.Twist Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Twist Bioscience's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Twist Bioscience could also be used in its relative valuation, which is a method of valuing Twist Bioscience by comparing valuation metrics of similar companies.Twist Bioscience is currently under evaluation in return on equity category among related companies.
Twist Fundamentals
| Return On Equity | -0.31 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (0.78) % | ||||
| Operating Margin | (0.66) % | ||||
| Current Valuation | 1.6 B | ||||
| Shares Outstanding | 57.82 M | ||||
| Shares Owned By Insiders | 1.78 % | ||||
| Shares Owned By Institutions | 98.22 % | ||||
| Number Of Shares Shorted | 12.26 M | ||||
| Price To Book | 3.01 X | ||||
| Price To Sales | 6.76 X | ||||
| Revenue | 245.11 M | ||||
| Gross Profit | 84.23 M | ||||
| EBITDA | (193.21 M) | ||||
| Net Income | (204.62 M) | ||||
| Cash And Equivalents | 504.97 M | ||||
| Cash Per Share | 8.93 X | ||||
| Total Debt | 94.07 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 6.58 X | ||||
| Book Value Per Share | 10.21 X | ||||
| Cash Flow From Operations | (142.47 M) | ||||
| Short Ratio | 16.80 X | ||||
| Earnings Per Share | (3.61) X | ||||
| Price To Earnings To Growth | (0.04) X | ||||
| Target Price | 40.25 | ||||
| Number Of Employees | 919 | ||||
| Beta | 1.63 | ||||
| Market Capitalization | 1.82 B | ||||
| Total Asset | 776.4 M | ||||
| Retained Earnings | (1.03 B) | ||||
| Working Capital | 350.93 M | ||||
| Net Asset | 776.4 M |
About Twist Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Twist Bioscience Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Twist Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Twist Bioscience Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 42.1 M | 44.2 M | |
| Total Revenue | 281.9 M | 296 M | |
| Cost Of Revenue | 178.7 M | 187.6 M | |
| Stock Based Compensation To Revenue | 0.14 | 0.25 | |
| Sales General And Administrative To Revenue | 1.19 | 1.28 | |
| Research And Ddevelopement To Revenue | 0.50 | 0.48 | |
| Capex To Revenue | (0.10) | (0.11) | |
| Revenue Per Share | 3.88 | 4.07 | |
| Ebit Per Revenue | (0.80) | (0.84) |
Twist Bioscience Investors Sentiment
The influence of Twist Bioscience's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Twist. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Twist Bioscience's public news can be used to forecast risks associated with an investment in Twist. The trend in average sentiment can be used to explain how an investor holding Twist can time the market purely based on public headlines and social activities around Twist Bioscience Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Twist Bioscience's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Twist Bioscience's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Twist Bioscience's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Twist Bioscience.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Twist Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Twist Bioscience's short interest history, or implied volatility extrapolated from Twist Bioscience options trading.
Currently Active Assets on Macroaxis
When determining whether Twist Bioscience Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Twist Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Twist Bioscience Corp Stock. Highlighted below are key reports to facilitate an investment decision about Twist Bioscience Corp Stock:Check out Twist Bioscience Piotroski F Score and Twist Bioscience Altman Z Score analysis. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Twist Stock analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.61) | Revenue Per Share 4.591 | Quarterly Revenue Growth 0.318 | Return On Assets (0.16) | Return On Equity (0.31) |
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.